Black Diamond Therapeutics, Inc. (BDTX) NASDAQ

2.67

+0.12(+4.71%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap117.76M
Enterprise Value103.51M
P/E Ratio7.07
PEG Ratio0.14
Price/Sales Ratio2.16
Price/Book Ratio1.2
Enterprise/Revenue1.95
Enterprise/EBITDA9.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.3
Operating Margin0.17

Management Effectiveness

Return On Assets0.14
Return On Equity0.18

Income Statement

Revenue0
Revenue/Share1.24
Gross Profit0
EBITDA-78.44M
Net Income-69.68M
Diluted EPS-1.27

Balance Sheet

Total Cash135.5M
Total Cash/Share0.54
Total Debt16.04M
Total Debt/Equity0.13
Current Ratio8.94
Book Value Per Share2.22

Price History

52-Week Change16.09
52-Week High4.94
52-Week Low1.2
Moving Average 50 Days3.57
Moving Average 200 Days2.73

Statistics

Average Volume1.23M
Shares Outstanding56.97M
% Held by Institutions68.27

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A